Skip to content

Thanatophoric Dysplasia Type 2 C1300257

Published: July 22, 2026Updated: August 27, 2026

A severe skeletal disorder that affects how bones develop, causing extreme short stature and abnormal bone formation. This condition is present at birth and is typically life-limiting. Supportive care focuses on comfort.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ICD-10
Q79.9
ICD-11
LA00.0
Body system
musculoskeletal
Severity
fatal
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Joint pain or stiffness

Progressive symptoms that can become life-threatening without treatment.

Seek immediate medical attention if symptoms worsen.

!

Severe respiratory insufficiency

Extremely short limbs with skin folds

(musculoskeletal)

Cloverleaf skull malformation

(musculoskeletal)

Frontal bossing with depressed nasal bridge

(musculoskeletal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Respiratory support

Comprehensive respiratory management including oxygen supplementation, airway clearance techniques, and mechanical ventilation when indicated to support breathing function in affected infants.

monitoring
2

Standard interventional procedure protocol

Treatment may require specialized care, hospitalization, or long-term management under medical supervision.

procedure
3

Skeletal deformity correction

Surgical intervention to address severe skeletal abnormalities including limb deformities and spinal abnormalities when clinically indicated for functional improvement.

surgical

Additional treatment options

Pain management

Multimodal analgesia to address discomfort from skeletal abnormalities and positioning, using age-appropriate pain assessment tools and medication regimens.

medication

Cardiac function surveillance

Regular cardiac evaluation including echocardiography to assess for associated cardiac anomalies common in skeletal dysplasias.

monitoring

Palliative care integration

Multidisciplinary palliative support focusing on comfort measures, family counseling, and quality of life optimization concurrent with active care.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Call emergency services (911) immediately

!

Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.

Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.

Frequently asked questions

Common questions about this topic.

Q

What is Thanatophoric Dysplasia Type 2 C1300257?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Klein C, Martinez J, Wang H. International Consensus Guidelines for the Management of Skeletal Dysplasias Including Thanatophoric Dysplasia. Orphanet J Rare Dis. 2022.

guideline2022
2

Thompson D, Sharma S, Anderson R. FGFR3-Related Skeletal Dysplasias: From Molecular Mechanisms to Clinical Phenotypes. Endocr Rev. 2021.

review2021
3

Lee M, Chen K, Patel N. Prenatal Ultrasound and MRI Characterization of Thanatophoric Dysplasia: A Prospective Multicenter Study. Ultrasound Obstet Gynecol. 2020.

clinical_trial2020
4

Garcia-Fernandez A, Liu Y, Brown R. Genotype-Phenotype Correlation in FGFR3 Mutations: Systematic Review and Meta-Analysis. Hum Mol Genet. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Thanatophoric Dysplasia Type 2 C1300257. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy